Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases
Clinical trial NCT04982172 · COMPLETED
Trial details
- NCT number
- NCT04982172
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2022-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.